Cardinal Health Raises Its Fiscal Year 2025 Outlook For Adjusted EPS To $7.75-$7.90 From Prior Guidance Of $7.55-$7.70 Versus Consensus Of $7.63
Portfolio Pulse from Benzinga Newsdesk
Cardinal Health has raised its fiscal year 2025 outlook for adjusted EPS to $7.75-$7.90, surpassing the consensus of $7.63. The company also updated its profit outlook for its Pharmaceutical and Specialty Solutions segment and its Global Medical Products and Distribution segment, as well as its adjusted free cash flow expectations.
November 01, 2024 | 10:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cardinal Health has increased its fiscal year 2025 adjusted EPS guidance to $7.75-$7.90, exceeding the consensus estimate of $7.63. The company also revised its profit outlook for key segments and raised its adjusted free cash flow expectations.
The increase in EPS guidance above consensus suggests a positive outlook for Cardinal Health, likely boosting investor confidence. The revised profit outlook for key segments and increased free cash flow expectations further support a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100